Wednesday, September 16, 2026Latest filing Sep 14, 2026

ESAB Congressional Stock Trades

ESAB Corporation Common Stock (ESAB)

Last disclosed trade Jul 7

Every disclosed trade in ESAB by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice.

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

Thomas H. Kean · Bought $ESAB · Jun 22 · $1K–$15K

0.28LOW
Disclosure speedx 0.250.30
Trade sizex 0.250.20
Cluster activityx 0.150.00
Track recordx 0.350.43

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow $ESAB

Get notified when any member of Congress trades $ESAB. Free, no card, no spam.

Follow free →
3
Disclosed trades
3
Buys
0
Sells
1
Members trading

The record on $ESAB

Coldpine has parsed 3 disclosed trades in $ESAB by 1 member of Congress, drawn from 2 periodic transaction reports dated Jun 22, 2026 through Jul 7, 2026. All of them came from House members, all filed by Republicans.

Of the 3 trades with a known filing lag, every one was reported inside the STOCK Act's 45-day window. The median lag was 23 days. The longest was 42 days: a $ESAB purchase by Thomas H. Kean dated Jul 7, 2026, disclosed Aug 18, 2026. How late filing is measured across all of Congress is in the late-filers study.

Members who trade ESAB

Recent disclosed trades in ESAB

DateMemberTypeAmount
Jul 7Thomas H. Kean(NJ)buy$1K–$15K
Jun 24Thomas H. Kean(NJ)buy$1K–$15K
Jun 22Thomas H. Kean(NJ)buy$1K–$15K

Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →